ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

N4P N4 Pharma Plc

0.775
-0.05 (-6.06%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -6.06% 0.775 0.75 0.80 0.825 0.775 0.83 611,345 15:32:48
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.35 1.39M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.83p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.175p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.39 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.35.

N4 Pharma Share Discussion Threads

Showing 4376 to 4395 of 8600 messages
Chat Pages: Latest  176  175  174  173  172  171  170  169  168  167  166  165  Older
DateSubjectAuthorDiscuss
03/8/2018
17:28
Is that the sound of the world's smallest violin? Grow up hugh and stop blaming your situation on 'traders', 'MMs' and 'derampers' .. I'm no efficient market proponent but the price is where it is because of sentiment and the perceived chances of success. Think it's oversold? Then buy more and stop bleating at me for being a bit more skeptical.
dplewis1
03/8/2018
17:10
Not naive Nobbo, Nigel and myself disagree on a number of things.
The effect of traders on a share price not being one of them.

Lewis, the deramper.
When have you ever done any analytical research. Your sole input on this thread from the day you started is to attack me and everything I say.

hughwilson
03/8/2018
17:02
Hugh and the word naive were made for each other....
nobbygnome
03/8/2018
16:17
Broker notes only slightly better than garbage on here.

They do spell Astrazeneca correctly, only saving grace.

escapetohome
03/8/2018
16:04
dplewis1, so you are entirely negative on any positive. No change there then and what you would expect of a deramper.
hughwilson
03/8/2018
14:22
Haha ..glad I never read those but as ih_ jokingly points out this is a new (bottom tier) broker that also has connections to a substantial shareholder..the rose tinted specs are well and truly on. Granted, it will delve into each area of the business and seem professional but there will also be a lot of fluff about the addressable market size of sildenafil, the potential of the vaccines business etc. There will probably be some finger in the air share price prediction that will get people salivating. But it will not be widely digested and if there's a bump to the share price it could well suffer from 'post recommendation drift' in the weeks after.
dplewis1
03/8/2018
14:20
looks finished
opodio
03/8/2018
14:16
Check out the brokers' notes from the two weeks before the Carillion news broke! Loads of other examples too.
gettingrichslow
03/8/2018
13:44
ih_575893,
Despite your sarcasm, a positive broker note will not have been compiled without due research.

hughwilson
03/8/2018
13:39
Ffs hugh.
What you mean the newly appointed broker isn’t going to produce a negative note?
Jeez.

ih_575893
03/8/2018
13:00
OneDayRodders, they will probably say it as Nigel does.They will look at the data, identify the failings and if it can be tweaked then they will do so, and then go for a second trial.
hughwilson
03/8/2018
12:53
That's good to hear hugh

Will be even more interesting to hear what part of the business they concentrate on.

onedayrodders
03/8/2018
12:43
I am expecting a highly positive brokers note from the new broker Allenby in the days ahead.
hughwilson
03/8/2018
12:12
No confidence whatsoever in any of these posts.

Useless non-information.

No confidence in n4p either.

escapetohome
02/8/2018
17:12
Strange widening of the spread at the end, you could still buy 50k at 8.67 if you so desired. Sunny Thursday night in the City..time for a few quick beers I think!
dplewis1
02/8/2018
16:50
Sweet lord. Let's keep to the topic folks.
jimbobaroony
02/8/2018
15:22
jpsbax,
5 against 1
Where I come from they call that a mugging.

hughwilson
02/8/2018
14:51
Jpsbax
Do you now agree that he’s a bell end??

eddie_yates
02/8/2018
11:56
Nobby, estimated cost of rerunning the trial was touted at around GBP 500k from what I recall.
dplewis1
02/8/2018
11:17
Yeah, apologies about that. Not as one sided as I first thought.
jpsbax
Chat Pages: Latest  176  175  174  173  172  171  170  169  168  167  166  165  Older

Your Recent History

Delayed Upgrade Clock